Data Supplement from Phase II Study of Single-Agent Orteronel (TAK-700) in Patients with Nonmetastatic Castration-Resistant Prostate Cancer and Rising Prostate-Specific Antigen
Year: 2023
Type: other
Abstract: Supplemental Figure 1. Median AMS scores for each parameter assessed: (A) total; (B) psychological; (C) sexual; (D) somatic.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361883626